Home › Funds › BANK OF MONTREAL /CAN/ › GILD

BANK OF MONTREAL /CAN/ position in GILD

GILEAD SCIENCES INC · Health Care

BANK OF MONTREAL /CAN/ reported holding 3,772,428 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$476.6M, representing 0.50% of its reported portfolio and ranking #39 among its reported holdings. BANK OF MONTREAL /CAN/ has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.77M sh
Reported value held$476.61M
Portfolio Weight0.50%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BANK OF MONTREAL /CAN/'s GILD position evolved

BANK OF MONTREAL /CAN/ first disclosed a stake in GILD in Q3 2023 at 2,764,928 shares (US$235.0M). The position peaked in Q1 2026 at 3,549,224 shares, worth US$494.7M. Across 12 filings, BANK OF MONTREAL /CAN/ increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 3,772,428 shares valued at US$476.6M — an increase of 223,204 shares quarter over quarter.. Notable position changes include a 100% trim in Q1 2025 (shares were roughly flat over the following quarter), a 555% increase in Q2 2025 (shares were roughly flat over the following quarter), a 11972% increase in Q1 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.76M $235.02M New
Q4 2023 4.67M $397.12M Add
Q1 2024 3.59M $305.51M Reduce
Q2 2024 4.35M $369.56M Add
Q3 2024 3.38M $282.36M Reduce
Q4 2024 3.30M $304.97M Reduce
Q1 2025 8.40K $941.22K Reduce
Q2 2025 55.00K $6.10M Add
Q3 2025 30.00K $3.33M Reduce
Q4 2025 29.40K $3.61M Reduce
Q1 2026 3.55M $494.66M Add
Q2 2026 3.77M $476.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has BANK OF MONTREAL /CAN/ held GILD?

BANK OF MONTREAL /CAN/ has disclosed GILD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BANK OF MONTREAL /CAN/'s current position in GILD?

As of Q2 2026, BANK OF MONTREAL /CAN/ holds 3.77M shares of GILD (GILEAD SCIENCES INC), valued at $476.61M, representing 0.50% of its reported portfolio and ranking #39.

Has BANK OF MONTREAL /CAN/ been buying or selling GILD?

In the latest 13F filing (Q2 2026), BANK OF MONTREAL /CAN/ increased its position in GILD. The position peaked in Q1 2026 at 3.55M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.